Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.60 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | LCK | P06239 | 1/20 | 0.48 |
| ▸ | PPARD | Q03181 | 1/20 | 0.48 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.48 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
| ▸ | GMNN | O75496 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | THPO | P40225 | 1/20 | 0.43 |
| ▸ | MTOR | P42345 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1237975 | 1.00 | GPR84 (0.60) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL425589 | 1.00 | GPR84 (0.60) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL168064 | 1.00 | GPR84 (0.60) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL167865 | 1.00 | GPR84 (0.60) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL17646227 | 1.00 | GPR84 (0.60) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL167222 | 1.00 | GPR84 (0.60) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL584656 | 1.00 | GPR84 (0.60) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL5740376 | 0.98 | GPR84 (0.57) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL2858482 | 0.96 | GPR84 (0.56) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL6910867 | 0.95 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 534 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021058158-A1 | PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING AMINOSILICONE, A CHROMOPHORIC COMPOUND AND ETHOXYLATED FATTY ACID ESTER | HENKEL AG & CO. KGAA (DE) | 2021-04-01 | — | — | WO | claimed |
| EP-2988731-B1 | COMPOSITION FOR USE IN REDUCING SCAB FORMATION AND PROMOTING HEALING | BIOGLAN AB (SE) | 2021-02-17 | — | — | EP | claimed |
| EP-3210474-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING POLYPEPTIDES AND RELATED METHODS OF DELIVERY | CHIASMA INC (US) | 2020-11-18 | — | — | EP | claimed |
| EP-3233035-B1 | THICKENING DEVELOPER FOR OXIDATION PRODUCTS | HENKEL AG & CO KGAA (DE) | 2019-05-01 | — | — | EP | claimed |
| EP-3233035-A1 | THICKENING DEVELOPER FOR OXIDATION DYES | Henkel AG & Co. KGaA (DE) | 2017-10-25 | — | — | EP | claimed |
| EP-2827829-B1 | PEG-FREE ANTIPERSPIRANT OIL-IN-WATER EMULSIONS HAVING IMPROVED FEEL | HENKEL AG & CO KGAA (DE) | 2017-02-08 | — | — | EP | claimed |
| WO-2016096223-A1 | THICKENING DEVELOPER FOR OXIDATION DYES | HENKEL AG & CO. KGAA (DE) | 2016-06-23 | — | — | WO | claimed |
| EP-2827829-A2 | PEG-FREE ANTIPERSPIRANT OIL-IN-WATER EMULSIONS HAVING IMPROVED FEEL | Henkel AG & Co. KGaA (DE) | 2015-01-28 | — | — | EP | claimed |
| WO-2013092186-A2 | PEG-FREE ANTIPERSPIRANT OIL-IN-WATER EMULSIONS HAVING IMPROVED FEEL | HENKEL AG & CO. KGAA (DE) | 2013-06-27 | — | — | WO | claimed |
| EP-1521573-B1 | NON-POLYMERIC LIPOPHILIC PHARMACEUTICAL IMPLANT COMPOSITIONS FOR INTRAOCULAR USE | ALCON INC (CH) | 2008-01-02 | — | — | EP | claimed |
| EP-1436299-A4 | METHOD FOR CRYSTALLIZATION OF 7-AMINOCEPHALOSPORANIC ACID | CKD BIO CORP (KR) | 2005-01-19 | — | — | EP | claimed |
| EP-1436299-A1 | METHOD FOR CRYSTALLIZATION OF 7-AMINOCEPHALOSPORANIC ACID | CKD BIO CORP. (KR) | 2004-07-14 | — | — | EP | claimed |
| WO-2003031451-A1 | METHOD FOR CRYSTALLIZATION OF 7-AMINOCEPHALOSPORANIC ACID | CKD BIO CORP. (KR) | 2003-04-17 | — | — | WO | claimed |
| EP-1250331-A1 | FORMULATION FOR PROTECTION AGAINST OXIDATIVE STRESS CONTAINING BENZOFURANONE DERIVATIVES | MERCK PATENT GmbH (DE) | 2002-10-23 | — | — | EP | claimed |
| WO-2001055128-A1 | FORMULATION FOR PROTECTION AGAINST OXIDATIVE STRESS CONTAINING BENZOFURANONE DERIVATIVES | MERCK PATENT GMBH (DE) | 2001-08-02 | — | — | WO | claimed |
| US-20230310391-A1 | COMBINATION OF AN ANTIMUSCARINIC OR AN ANTICHOLINERGIC AGENT AND LIPOIC ACID AND USES THEREOF | CELLIX BIO PRIVATE LIMITED (IN) | 2023-10-05 | — | — | US | disclosed |
| US-11730864-B2 | Drug coated balloon catheters for nonvascular strictures | UROTRONIC, INC. (US) | 2023-08-22 | — | — | US | disclosed |
| EP-0775481-A1 | Stable and free of hydrocarbons cosmetic or dermatologic oleogels and O/W emulsions | Beiersdorf Aktiengesellschaft (DE) | 1997-05-28 | — | — | EP | disclosed |
| WO-1996028131-A2 | COSMETIC OR PHARMACEUTICAL MICROEMULSIONS | BEIERSDORF AG (DE) | 1996-09-19 | — | — | WO | disclosed |
| WO-1996028132-A2 | COSMETIC OR DERMATOLOGICAL GELS BASED ON MICROEMULSIONS | BEIERSDORF AG (DE) | 1996-09-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230310391-A1 | COMBINATION OF AN ANTIMUSCARINIC OR AN ANTICHOLINERGIC AGENT AND LIPOIC ACID AND USES THEREOF | ACHE, CHRM2, ALOX5 | GPR84 2361/4885FFAR1 1517/4885MAPT 2370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.